查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
GLP-1受體激動劑市場 - 按藥物類別（Semaglutide、Dulaglutide、Liraglutide、Exenatide），按給藥途徑（腸外），按應用（2型糖尿病、肥胖症），按分銷（醫院、零售），全球預測，2023 - 2032
市場調查報告書
商品編碼
1292429

GLP-1受體激動劑市場 - 按藥物類別（Semaglutide、Dulaglutide、Liraglutide、Exenatide），按給藥途徑（腸外），按應用（2型糖尿病、肥胖症），按分銷（醫院、零售），全球預測，2023 - 2032

GLP-1 Receptor Agonist Market - By Drug Class (Semaglutide, Dulaglutide, Liraglutide, Exenatide), By Route of Administration (Parenteral), By Application (Type 2 Diabetes, Obesity), By Distribution (Hospital, Retail), Global Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

由於糖尿病的高發率和病人對使用GLP-1受體激動劑的好處認知的提高，GLP-1受體激動劑市場將在2023年至2032年見證大幅成長。 GLP-1受體激動劑通過模仿調節血糖的胰高血糖素樣肽-1激素的作用而發揮作用。這些藥物有助於刺激胰島素的釋放，延緩胃排空，促進飽腹感，同時抑制胰高血糖素的釋放。

這些藥物通過注射給藥，以其在降低血糖水平、促進減肥和改善心血管狀況方面的有效性而聞名。隨著糖尿病人口的持續激增，對GLP-1受體激動劑的需求將不斷成長，推動市場成長。患者教育計劃、宣傳工作和保健運動大大促進了人們對這些藥物的認知和了解。此外，製藥公司正在投資研發，開發新的配方，以提高療效、便利性和病人的依從性。這些創新和管線發展將擴大GLP-1受體激動劑療法的可用選擇，最終支持行業成長。

GLP-1受體激動劑市場根據藥物種類、應用和地區進行分類。

按照藥物類別，由於艾塞那肽GLP-1受體激動劑在治療2型糖尿病方面的廣泛應用，到2032年，艾塞那肽部分將積累一個體面的估值。這些藥物在降低血糖水平、促進減肥和改善心血管狀況方面的有效性，有利於它們的採用。此外，基於艾塞那肽的新製劑的不斷推出將刺激該領域在未來十年的成長。

根據應用，估計到2032年，肥胖症部分將在GLP-1受體激動劑市場上佔有相當大的佔有率。 GLP-1受體激動劑通過減少食慾、促進飽腹感和幫助減肥，在管理肥胖症方面顯示出良好的效果。隨著全球肥胖症疫情的持續上升，對有效的肥胖症管理方案和非手術及藥物減肥方法的需求不斷增加，從而促進了市場成長。

從區域上看，歐洲GLP-1受體激動劑市場到2032年將占到相當大的收入佔有率，原因包括該地區糖尿病和肥胖症的發病率不斷上升，以及人們對個性化醫療和創新治療方法的日益重視等幾個因素。此外，有利的報銷政策、促進糖尿病管理的政府計劃以及成熟的市場參與者的存在將推動GLP-1受體激動劑在該地區的應用。

目錄

第一章：方法和範圍

第二章：執行摘要

第三章: GLP-1受體激動劑市場洞察力

  • 行業格局，2018 - 2032
  • 行業影響力量
    • 成長動力
      • 糖尿病和肥胖症等慢性病的發病率不斷上升
      • 開發新型療法的研發活動不斷增加
      • 口服GLP-1受體激動劑的配方進步
      • 對糖尿病的診斷和治療方案的認知不斷提高
    • 行業隱患和挑戰
      • 與少數GLP-1受體激動劑藥物有關的不良反應
      • 市場參與者的產品召回
  • 成長潛力分析
    • 按藥物類別
    • 按給藥途徑分類
    • 按應用分類
    • 按配銷通路分類
  • COVID-19的影響分析
  • 臨床試驗分析
  • 監管情況
  • 波特的分析
  • PESTEL分析

第四章：競爭格局，2022年

  • 簡介
  • 2022年公司矩陣分析
  • 2022年全球公司市場佔有率分析
  • 競爭定位矩陣，2022年
  • 戰略儀表板，2022年

第五章：GLP-1受體激動劑市場估計和預測：按藥物類別分類

  • 主要趨勢，按藥物類別
  • 塞馬魯肽
  • 杜拉魯肽（Dulaglutide
  • 利拉魯肽
  • 艾塞那肽
  • 其他藥物類別

第六章：GLP-1受體激動劑市場估計和預測：按給藥途徑分類

  • 主要趨勢，按給藥途徑
  • 靜脈注射
  • 口服

第七章：GLP-1受體激動劑市場估計和預測：按應用分類

  • 主要趨勢，按應用分類
  • 2型糖尿病
  • 肥胖症
  • 其他應用

第八章：GLP-1受體激動劑市場估計和預測：按配銷通路分類

  • 主要趨勢，按配銷通路
  • 醫院藥房
  • 零售藥店
  • 網上藥店

第九章：GLP-1受體激動劑市場估計和預測：按地區分類

  • 主要趨勢，按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 瑞士
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 亞太其他地區
  • 拉美地區
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 中東和非洲其他地區

第十章：公司簡介

  • Eli Lilly and Company
  • Sanofi
  • Novo-Nordisk A/S
  • AstraZeneca
  • Pfizer, Inc.
  • Amgen, Inc.
  • Innovent Biologics, Inc.
  • PegBio Co., Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim International GmbH
Product Code: 5864

GLP-1 Receptor Agonist Market is poised to witness significant growth from 2023 to 2032 owing to the high prevalence of diabetes and increasing patient awareness about the benefits of using GLP-1 receptor agonists. GLP-1 receptor agonists work by mimicking the action of glucagon-like peptide-1 hormone that regulates blood sugar. These medications help stimulate the release of insulin, slow-down gastric emptying and promote a feeling of fullness while inhibiting the release of glucagon.

These drugs are administered via injections and are known for their effectiveness in reducing blood sugar levels, promoting weight loss, and improving cardiovascular outcomes. With the continuous surge in the diabetic population, the demand for GLP-1 receptor agonists is poised to grow, driving the market growth. Patient education programs, advocacy efforts, and healthcare campaigns have significantly contributed to the increased awareness and understanding of these drugs. Furthermore, pharmaceutical companies are investing in R&D to develop new formulations with improved efficacy, convenience, and patient compliance. These innovations and pipeline developments will expand the available options for GLP-1 receptor agonist therapies, eventually supporting industry growth.

The GLP-1 receptor agonist market is categorized based on drug class, application, and region.

As per drug class, the exenatide segment will amass a decent valuation by 2032, owing to the widespread application of exenatide GLP-1 receptor agonists in treating type 2 diabetes. The effectiveness of these drugs in reducing blood sugar levels, promoting weight loss, and improving cardiovascular outcomes has favored their adoption. Additionally, the continuous rollouts of new exenatide-based formulations will stimulate segment growth over the next ten years.

Based on application, the obesity segment is estimated to hold a sizable share of the GLP-1 receptor agonists market by 2032. GLP-1 receptor agonists have shown promising results in managing obesity by reducing appetite, promoting satiety, and aiding in weight loss. As the global obesity epidemic continues to rise, there is an increasing demand for effective obesity management options and non-surgical and pharmacological approaches to weight loss, thereby contributing to market growth.

Regionally, the Europe GLP-1 receptor agonists market is set to account for a substantial revenue share by 2032 due to several factors including the increasing prevalence of diabetes and obesity in the region, along with a growing focus on personalized medicine and innovative treatment approaches. Additionally, favorable reimbursement policies, government initiatives promoting diabetes management, and the presence of established market players will drive the adoption of GLP-1 receptor agonists across the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Covid-19 impact analysis at global level
  • 1.5 Data Validation
  • 1.6 Data Sources
    • 1.6.1 Secondary
      • 1.6.1.1 Paid sources
      • 1.6.1.2 Public sources
    • 1.6.2 Primary

Chapter 2 Executive Summary

  • 2.1 GLP-1 receptor agonist industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Region trends
    • 2.1.3 Drug class trends
    • 2.1.4 Route of administration
    • 2.1.5 Application trends
    • 2.1.6 Distribution channel trends

Chapter 3 GLP-1 Receptor Agonist Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic diseases such as diabetes and obesity
      • 3.2.1.2 Increasing R&D activities for developing novel therapeutics
      • 3.2.1.3 Formulation advancements of oral GLP-1 receptor agonists
      • 3.2.1.4 Increasing awareness about diagnosis and treatment options for diabetes
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Adverse effects associated with few GLP-1 agonist drugs
      • 3.2.2.2 Product recalls by market players
  • 3.3 Growth potential analysis
    • 3.3.1 By drug class
    • 3.3.2 By route of administration
    • 3.3.3 By application
    • 3.3.4 By distribution channel
  • 3.4 COVID-19 impact analysis
  • 3.5 Clinical trial analysis
  • 3.6 Regulatory landscape
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Global company market share analysis, 2022
  • 4.4 Competitive positioning matrix, 2022
  • 4.5 Strategic dashboard, 2022

Chapter 5 GLP-1 Receptor Agonist Market Estimates and Forecast, By Drug Class (USD Million)

  • 5.1 Key trends, by drug class
  • 5.2 Semaglutide
  • 5.3 Dulaglutide
  • 5.4 Liraglutide
  • 5.5 Exenatide
  • 5.6 Other drug classes

Chapter 6 GLP-1 Receptor Agonist Market Estimates and Forecast, By Route of Administration (USD Million)

  • 6.1 Key trends, by route of administration
  • 6.2 Parenteral
  • 6.3 Oral

Chapter 7 GLP-1 Receptor Agonist Market Estimates and Forecast, By Application (USD Million)

  • 7.1 Key trends, by application
  • 7.2 Type 2 diabetes mellitus
  • 7.3 Obesity
  • 7.4 Other applications

Chapter 8 GLP-1 Receptor Agonist Market Estimates and Forecast, By Distribution Channel (USD Million)

  • 8.1 Key trends, by distribution channel
  • 8.2 Hospital pharmacies
  • 8.3 Retail pharmacies
  • 8.4 Online pharmacies

Chapter 9 GLP-1 Receptor Agonist Market Estimates and Forecast, By Region (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Switzerland
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

  • 10.1 Eli Lilly and Company
  • 10.2 Sanofi
  • 10.3 Novo-Nordisk A/S
  • 10.4 AstraZeneca
  • 10.5 Pfizer, Inc.
  • 10.6 Amgen, Inc.
  • 10.7 Innovent Biologics, Inc.
  • 10.8 PegBio Co., Ltd.
  • 10.9 Sun Pharmaceutical Industries Ltd.
  • 10.10 Boehringer Ingelheim International GmbH

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by drug class (2022)
  • TABLE 3 Market revenue, by route of administration (2022)
  • TABLE 4 Market revenue, by application (2022)
  • TABLE 5 Market revenue, by distribution channel (2022)
  • TABLE 6 Market share, by region (2022)
  • TABLE 7 Global GLP-1 receptor agonist market size, by region, 2018 - 2022 (USD Million)
  • TABLE 8 Global GLP-1 receptor agonist market size, by region, 2023 - 2032 (USD Million)
  • TABLE 9 Global GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 10 Global GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 11 Global GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 12 Global GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 13 Global GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 14 Global GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 15 Global GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 16 Global GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 17 Industry impact forces
  • TABLE 18 Competitive benchmarking of major market players
  • TABLE 19 Competitive positioning matrix: Classification criteria
  • TABLE 20 Strategic outlook matrix: Classification criteria
  • TABLE 21 Semaglutide market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 22 Semaglutide market size by drug type, 2023 - 2032 (USD Million)
  • TABLE 23 Dulaglutide market size, 2018 - 2022 (USD Million)
  • TABLE 24 Dulaglutide market size, 2023 - 2032 (USD Million)
  • TABLE 25 Liraglutide market size, 2018 - 2022 (USD Million)
  • TABLE 26 Liraglutide market size, 2023 - 2032 (USD Million)
  • TABLE 27 Exenatide market size, 2018 - 2022 (USD Million)
  • TABLE 28 Exenatide market size, 2023 - 2032 (USD Million)
  • TABLE 29 Other drug classes market size, 2018 - 2022 (USD Million)
  • TABLE 30 Other drug classes market size, 2023 - 2032 (USD Million)
  • TABLE 31 Parenteral market size, 2018 - 2022 (USD Million)
  • TABLE 32 Parenteral market size, 2023 - 2032 (USD Million)
  • TABLE 33 Oral market size, 2018 - 2022 (USD Million)
  • TABLE 34 Oral market size, 2023 - 2032 (USD Million)
  • TABLE 35 Type 2 diabetes mellitus market size, 2018 - 2022 (USD Million)
  • TABLE 36 Type 2 diabetes mellitus market size, 2023 - 2032 (USD Million)
  • TABLE 37 Obesity market size, 2018 - 2022 (USD Million)
  • TABLE 38 Obesity market size, 2023 - 2032 (USD Million)
  • TABLE 39 Other applications market size, 2018 - 2022 (USD Million)
  • TABLE 40 Other applications market size, 2023 - 2032 (USD Million)
  • TABLE 41 Hospital pharmacies market size, 2018 - 2022 (USD Million)
  • TABLE 42 Hospital pharmacies market size, 2023 - 2032 (USD Million)
  • TABLE 43 Retail pharmacies market size, 2018 - 2022 (USD Million)
  • TABLE 44 Retail pharmacies market size, 2023 - 2032 (USD Million)
  • TABLE 45 Online pharmacies market size, 2018 - 2022 (USD Million)
  • TABLE 46 Online pharmacies market size, 2023 - 2032 (USD Million)
  • TABLE 47 North America GLP-1 receptor agonist market size, by country, 2018 - 2022 (USD Million)
  • TABLE 48 North America GLP-1 receptor agonist market size, by country, 2023 - 2032 (USD Million)
  • TABLE 49 North America GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 50 North America GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 51 North America GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 52 North America GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 53 North America GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 54 North America GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 55 North America GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 56 North America GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 57 U.S. GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 58 U.S. GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 59 U.S. GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 60 U.S. GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 61 U.S. GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 62 U.S. GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 63 U.S. GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 64 U.S. GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 65 Canada GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 66 Canada GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 67 Canada GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 68 Canada GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 69 Canada GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 70 Canada GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 71 Canada GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 72 Canada GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 73 Europe GLP-1 receptor agonist market size, by country, 2018 - 2022 (USD Million)
  • TABLE 74 Europe GLP-1 receptor agonist market size, by country, 2023 - 2032 (USD Million)
  • TABLE 75 Europe GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 76 Europe GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 77 Europe GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 78 Europe GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 79 Europe GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 80 Europe GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 81 Europe GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 82 Europe GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 83 Germany GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 84 Germany GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 85 Germany GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 86 Germany GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 87 Germany GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 88 Germany GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 89 Germany GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 90 Germany GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 91 UK GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 92 UK GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 93 UK GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 94 UK GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 95 UK GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 96 UK GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 97 UK GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 98 UK GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 99 France GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 100 France GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 101 France GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 102 France GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 103 France GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 104 France GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 105 France GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 106 France GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 107 Spain GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 108 Spain GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 109 Spain GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 110 Spain GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 111 Spain GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 112 Spain GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 113 Spain GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 114 Spain GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 115 Italy GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 116 Italy GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 117 Italy GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 118 Italy GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 119 Italy GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 120 Italy GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 121 Italy GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 122 Italy GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 123 Switzerland GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 124 Switzerland GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 125 Switzerland GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 126 Switzerland GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 127 Switzerland GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 128 Switzerland GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 129 Switzerland GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 130 Switzerland GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 131 Rest of Europe GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 132 Rest of Europe GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 133 Rest of Europe GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 134 Rest of Europe GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 135 Rest of Europe GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 136 Rest of Europe GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 137 Rest of Europe GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 138 Rest of Europe GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 139 Asia Pacific GLP-1 receptor agonist market size, by country, 2018 - 2022 (USD Million)
  • TABLE 140 Asia Pacific GLP-1 receptor agonist market size, by country, 2023 - 2032 (USD Million)
  • TABLE 141 Asia Pacific GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 142 Asia Pacific GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 143 Asia Pacific GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 144 Asia Pacific GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 145 Asia Pacific GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 146 Asia Pacific GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 147 Asia Pacific GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 148 Asia Pacific GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 149 China GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 150 China GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 151 China GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 152 China GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 153 China GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 154 China GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 155 China GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 156 China GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 157 Japan GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 158 Japan GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 159 Japan GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 160 Japan GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 161 Japan GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 162 Japan GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 163 Japan GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 164 Japan GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 165 India GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 166 India GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 167 India GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 168 India GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 169 India GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 170 India GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 171 India GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 172 India GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 173 Australia GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 174 Australia GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 175 Australia GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 176 Australia GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 177 Australia GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 178 Australia GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 179 Australia GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 180 Australia GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 181 South Korea GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 182 South Korea GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 183 South Korea GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 184 South Korea GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 185 South Korea GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 186 South Korea GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 187 South Korea GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 188 South Korea GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 189 Rest of Asia Pacific GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 190 Rest of Asia Pacific GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 191 Rest of Asia Pacific GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 192 Rest of Asia Pacific GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 193 Rest of Asia Pacific GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 194 Rest of Asia Pacific GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 195 Rest of Asia Pacific GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 196 Rest of Asia Pacific GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 197 Latin America GLP-1 receptor agonist market size, by country, 2018 - 2022 (USD Million)
  • TABLE 198 Latin America GLP-1 receptor agonist market size, by country, 2023 - 2032 (USD Million)
  • TABLE 199 Latin America GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 200 Latin America GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 201 Latin America GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 202 Latin America GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 203 Latin America GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 204 Latin America GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 205 Latin America GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 206 Latin America GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 207 Brazil GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 208 Brazil GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 209 Brazil GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 210 Brazil GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 211 Brazil GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 212 Brazil GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 213 Brazil GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 214 Brazil GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 215 Mexico GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 216 Mexico GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 217 Mexico GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 218 Mexico GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 219 Mexico GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 220 Mexico GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 221 Mexico GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 222 Mexico GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 223 Rest of Latin America GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 224 Rest of Latin America GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 225 Rest of Latin America GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 226 Rest of Latin America GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 227 Rest of Latin America GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 228 Rest of Latin America GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 229 Rest of Latin America GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 230 Rest of Latin America GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 231 Middle East & Africa GLP-1 receptor agonist market size, by country, 2018 - 2022 (USD Million)
  • TABLE 232 Middle East & Africa GLP-1 receptor agonist market size, by country, 2023 - 2032 (USD Million)
  • TABLE 233 Middle East & Africa GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 234 Middle East & Africa GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 235 Middle East & Africa GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 236 Middle East & Africa GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 237 Middle East & Africa GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 238 Middle East & Africa GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 239 Middle East & Africa GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 240 Middle East & Africa GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 241 South Africa GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 242 South Africa GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 243 South Africa GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 244 South Africa GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 245 South Africa GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 246 South Africa GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 247 South Africa GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 248 South Africa GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 249 Saudi Arabia GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 250 Saudi Arabia GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 251 Saudi Arabia GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 252 Saudi Arabia GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 253 Saudi Arabia GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 254 Saudi Arabia GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 255 Saudi Arabia GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 256 Saudi Arabia GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 257 Rest of Middle East & Africa GLP-1 receptor agonist market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 258 Rest of Middle East & Africa GLP-1 receptor agonist market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 259 Rest of Middle East & Africa GLP-1 receptor agonist market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 260 Rest of Middle East & Africa GLP-1 receptor agonist market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 261 Rest of Middle East & Africa GLP-1 receptor agonist market size, by application, 2018 - 2022 (USD Million)
  • TABLE 262 Rest of Middle East & Africa GLP-1 receptor agonist market size, by application, 2023 - 2032 (USD Million)
  • TABLE 263 Rest of Middle East & Africa GLP-1 receptor agonist market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 264 Rest of Middle East & Africa GLP-1 receptor agonist market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 GLP-1 receptor agonist industry 36 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by drug class
  • FIG 8 Growth potential analysis, by route of administration
  • FIG 9 Growth potential analysis, by application
  • FIG 10 Growth potential analysis, by distribution channel
  • FIG 11 Porter's analysis
  • FIG 12 PESTEL analysis
  • FIG 13 Company matrix analysis, 2022
  • FIG 14 Global Company market share analysis, 2022
  • FIG 15 Competitive positioning matrix, 2022
  • FIG 16 Strategic dashboard, 2022